Skip to content
Home
Technology
Company
News
In the News
Press Releases
Contact
Menu
Home
Technology
Company
News
In the News
Press Releases
Contact
Micron Biomedical
Press Releases
Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles
November 16, 2023
Read More
Micron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of Directors
August 9, 2023
Read More
Micron Biomedical Announces Positive Measles and Rubella Vaccination Results from First Clinical Trial of Microarray Injection-Free Vaccine Delivery in Children
May 17, 2023
Read More
Micron Biomedical Extends Series A to $17 Million to Bring Needle-Free Drugs and Vaccines to Market
May 10, 2023
Read More
Micron Biomedical Secures Series A Financing to Commercialize MAP Technology for Self-Administration of Drugs and Vaccines without Needles
November 28, 2022
Read More
Micron Biomedical Presents at the White House Summit on the Future of COVID-19 Vaccines
July 26, 2022
Read More
Micron Biomedical Initiates First-Ever Microneedle Vaccine Clinical Trial in Children
July 13, 2021
Read More
Micron receives contract from CDC to manufacture IRV microneedle patches
November 12, 2020
Read More
Top 10 Emerging Technologies of 2020
November 10, 2020
Read More
Micron developing microneedle technology for self-administration of vaccines and therapeutics
November 3, 2020
Read More
Steven Damon Appointed Chief Executive Officer of Micron Biomedical
June 1, 2020
Read More
Microneedle patch technology shows potential for long-acting contraception
January 14, 2019
Read More
Load More